At a glance
ClinicalIndex Comparison RecordN/ACompleted· 114 enrolled
Drug / intervention
observational studyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
In Brief
An observational study evaluating observational study for Hemorrhage and Bleeding. Completed, enrolled 114 participants across 39 sites.
Detailed Summary
The rFVIIa (Novoseven) has been tested in traumatic hemorrhage but its efficiency has not been proven yet in this context. A national register has been set up in France identifying the patients which received rFVIIa. Those patients had persistent and active bleeding after severe trauma despite surgery and/or interventional radiology embolization. The aim of this present study is to report the first clinical results in those situations of patients treated with rFVIIa.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHemorrhage, Bleeding
CountriesFrance
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2008
First PostedFeb 2012
Primary CompletionSep 2012
Study CompletionDec 2012
TodayJul 2026
First PostedFeb 14, 2012
Enrollment StartApr 1, 2008
Primary CompletionSep 1, 2012
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 14.4 years ago
Interventions
observational studyother
data collected by investigators